Figure S2. JNK or p38 inhibitors decreased the cell apoptosis. A, control shRNA/HSP90AA1 shRNA transfected MG-63 cells were treated with Dox (0.2 μg/mL) for 24 h with or without SP600125. Apoptosis was analyzed by measuring Annexin V-PE/PI positive cells by flow cytometric (n = 3; *, p < 0.05 versus control shRNA group). B, control shRNA/HSP90AA1 shRNA transfected MG-63 cells were treated with Dox (0.2 μg/mL) for 24 h with or without SB203580. Apoptosis was analyzed by measuring Annexin V-PE/PI positive cells by flow cytometric (n = 3; *, p < 0.05 versus control shRNA group). NS, not significant. (PDF 88 kb
(A) The expression of ASPP2 was detected in BxPC-3 cells with stable ASSP2 over-expression and SW199...
Additional file 1: Figure S1. Caspase-3 and PI measurement upon treatments. A) Apoptosis activation ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Figure S1. Normalized quantification of all immunoblots in the manuscript. A, The normalized quantif...
The up-regulation of S100A9 enhanced osteosarcoma proliferation, migration and invasion.A.The protei...
Figure S1. Knockdown of COPS3 reduces the migratory and invasive abilities of osteosarcoma cells thr...
Supplementary Tables. Table S1. shRNA target sequence used in the experiments. Table S2. Primers use...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S2. COPS3 downregulation did not significantly affect tumorigenesis of osteosarcoma cells. (a...
Knockdown of HSP90 reduced the protein level of PKM2. Hep3B cells were transfected with HSP90 shRNA ...
Pancreatic CSCs enriched by sphere formation exhibit increased chemoresistance and anti-apoptotic ac...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
The knockdown of S100A9 had no effect on the cell apoptosis, RAGE or TLR4. A. The apoptosis was test...
Figure S2. The histogram of the WB results. *P < 0.05, significantly different compared with the con...
OPN triggered STAT3, ERK, and NF-κB activation, but not AKT, JNK, and p38 MAPK in pancreatic cancer ...
(A) The expression of ASPP2 was detected in BxPC-3 cells with stable ASSP2 over-expression and SW199...
Additional file 1: Figure S1. Caspase-3 and PI measurement upon treatments. A) Apoptosis activation ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...
Figure S1. Normalized quantification of all immunoblots in the manuscript. A, The normalized quantif...
The up-regulation of S100A9 enhanced osteosarcoma proliferation, migration and invasion.A.The protei...
Figure S1. Knockdown of COPS3 reduces the migratory and invasive abilities of osteosarcoma cells thr...
Supplementary Tables. Table S1. shRNA target sequence used in the experiments. Table S2. Primers use...
Figure S8. Autophagy inhibitors counteract palbociclib-mediated antagonism on bortezomib-induced cel...
Figure S2. COPS3 downregulation did not significantly affect tumorigenesis of osteosarcoma cells. (a...
Knockdown of HSP90 reduced the protein level of PKM2. Hep3B cells were transfected with HSP90 shRNA ...
Pancreatic CSCs enriched by sphere formation exhibit increased chemoresistance and anti-apoptotic ac...
Figure S7. Palbociclib treatment induces autophagy but not after a short treatment period. (A) MCL c...
The knockdown of S100A9 had no effect on the cell apoptosis, RAGE or TLR4. A. The apoptosis was test...
Figure S2. The histogram of the WB results. *P < 0.05, significantly different compared with the con...
OPN triggered STAT3, ERK, and NF-κB activation, but not AKT, JNK, and p38 MAPK in pancreatic cancer ...
(A) The expression of ASPP2 was detected in BxPC-3 cells with stable ASSP2 over-expression and SW199...
Additional file 1: Figure S1. Caspase-3 and PI measurement upon treatments. A) Apoptosis activation ...
Figure S9. Co-treatment of bortezomib with autophagy inhibitors potentiates cell death induction. MC...